The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WILL TRUMP’S LACK OF LEADERSHIP BECOME AN EXCUSE FOR A BIG SELLOFF IN STOCKS? $GS $AMAT $BABA $WMT $ROST $SPY $GLD

August 17, 2017

In my 30-plus years in the markets, I have learned that overbought markets are always vulnerable. Overbought markets look for an excuse to sell off. Unfortunately, many less experienced investors do not understand that simple observation and end up losing money. The chart Please click here to see money flows segmented into three categories. Please note from the chart that the “momo” (momentum) crowd was a big seller in the market decline. The same investors were aggressively buying when the market was going up. The momo crowd gets into the cycle of buying high and selling low. The situation may

Read More »

WEEKLY MARKET DIGEST: IMPLICATIONS OF N. KOREA FOR STOCKS, GOLD, BONDS AND CURRENCIES; LOWER OIL DEMAND $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

August 11, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. LOW LIQUIDITY, TAMER CPI, TOUGHER TALK, HIGHER GOLD, LOWER OIL DEMAND August 11, 2017 This is what you need to know today. Low Liquidity Liquidity in

Read More »

LOWES WENT INTO THE TARGET ZONE, ALL SUBSCRIBERS SHOULD HAVE TAKEN PROFITS $LOW

August 11, 2017

This post was just published on ZYX Buy Change Alert. It appears that many subscribers are still holding LOW.  LOW went into the target zone to $78.91.  The target zone was $78.68 to $81.  When a stock reaches the target zone, if attempting to get a higher price, it is important to put stops in a tight zone under the target zone.  A better alternative is to use price pattern on a three minute chart to see if it makes sense to get out at a certain price in the target zone.  In the case of LOW, if using price action, it made

Read More »

HOW HIGH CAN GOLD GO? $GLD $NUGT $DUST $GC_F $GDX $GDXJ $SLV

August 11, 2017

When the news hit that North Korea had succeeded at miniaturizing a nuclear warhead, I gave a call to buy gold in The Arora Report ZYX Global Multi Asset Allocation Alert when it was trading around $1260.   As of this writing, gold is trading at $1284. For most investors, the call was to buy gold ETF GLD. In The Arora Report ZYX Buy Change Alert, I gave a call to buy triple leveraged gold miner ETF NUGT at $29.12 for aggressive investors in lieu of gold ETF GLD.  It is trading at $31.24 as of this writing. Partial profits have

Read More »

GOLD KEY SUPPORT RESISTANCE ZONES AND MONEY FLOWS $GLD $SLV $GDX $GDXJ $NUGT $DUST

August 9, 2017

This post was just published on ZYX Buy Change Alert. The Arora Report provides eight types of information on gold, silver, miners and other precious metals. Signals meet our criteria and have produced unrivaled performance in both bull and bear markets.  Signals range from very long-term generational opportunities to very short-term.  Depending upon market conditions, many signals may be issued in a short time or no signals may be issued for a long time. Signals Limited do not meet our strict criteria but have significant merit for aggressive investors. Ratings are provided for six different time frames for those who always want to

Read More »

BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

August 9, 2017

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly mistakes. It just badly hurt those who had bought shares of Teva Pharmaceutical Industries TEVA,  because of its high dividend yield. This isn’t just an issue for Teva investors, of course. There are many companies whose share price is being held up by dividend chasers. Take what happened in this case, however, as a reminder to review your portfolio and then sell those dividend-paying stocks where underlying businesses are deteriorating. In the case of Teva, the warning signs were

Read More »

WEEKLY MARKET DIGEST: PREPARE FOR POTENTIAL FRONT RUNNING OF SEPTEMBER IN AUGUST, GOLD SOLD $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

August 5, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. STRONG JOBS REPORT, MUELLER IMPANELS GRAND JURY, GOLD SOLD August 4, 2017 This is what you need to know today. Strong Jobs Report Non-farm Private Payrolls

Read More »

A NEW IDEA ON UNITED THERAPEUTICS, BUYOUT RUMORS AT $200 $UTHR $GSK $GILD

August 4, 2017

This post was just published on ZYX Buy Change Alert. UTHR is a biotech company.  It closed at $127.92.  There are rumors that GSK and GILD are competing to buy the company at around $200.  Based on rumors the stock has moved up to $138 in the pre-market. Consider accumulating up to 25% of the full core position size on any dip in the zone of $126 to $135.52. Consider scaling in in the smallest tranche that your account will allow as the stock can trade in a very wide range.  Stop zone is $113 to $117.43. This is suitable only for aggressive

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content